The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide BPC 157 Intra V FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News Compounded "semaglutide" is not FDA approved semaglutide.com